Clinical investigation of photodynamic therapy and intravitreal Avastin for choroidal neovascularization due to pathologic myopia

International Eye Science

Volumn 12, Issue 6, 2012, Pages 1063-1065

  Hu, Yi Qun ^a   Chen, Qing Shan ^a   Fang, Min ^a   Yang, Xu ^a  

^a JINAN UNIVERSITY   (China)

Author keywords

Avastin; Choroidal neovascularization; Pathologic myopia; Photodynamic therapy

Indexed keywords

BEVACIZUMAB; VERTEPORFIN;

ANGIOGRAPHY; ARTICLE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CORNEA THICKNESS; DRUG EFFICACY; DRUG SAFETY; EYE FUNDUS; FOLLOW UP; HUMAN; MYOPIA; OPTICAL COHERENCE TOMOGRAPHY; PATHOLOGY; PHOTODYNAMIC THERAPY; PROGNOSIS; RETINA FOVEA; STUDENT T TEST; SUBRETINAL NEOVASCULARIZATION; VISUAL ACUITY;

EID: 84861933063     PISSN: 16725123     EISSN: None     Source Type: Journal    
DOI: 10.3969/j.issn.1672-5123.2012.06.15     Document Type: Article

References (17)

1. Miller J W, Schmidt-Erfuth U, Sickenberg M, et al. Photodynamic therapy for choroidal neovascularization caused by age-related macular degeneration: result of a single treatment in a phase 1 and 2 study. Arch Ophthalmol 1999; 117 (9): 1161-1173
2. Treatment of age-related macular degeneration with photodynamic therapy (TAP) study group. Verteporfin therapy for subfoveal choroidal neovascu-larization in age-related macular degeneration. Three-year results of an open-label extension of 2 randomized clinical trials. TAP Report No. 5. Arch Ophthalmol 2002; 120 (10): 1307-1314
3. Verteporfin in Photodynamic Therapy (VIP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin. 1-year results of a randomized clinical trial-VIP Report No. 1. Ophthalmology 2001; 108(5): 841-852
4. Blinder K J, Blumenkranz M S, Bressler N M, et al. Verteporfin therapy of subfoveal choroidal neovascularization in pathologic myopia: two-year results of a randomized clinical trial-VIP Report No. 3. Ophthalmology 2003; 110 (4): 667-673
5. Cohen S Y, Laroche A, Leguen Y, et al. Etiology of choroidal neovascularization in young patients. Ophthalmology 1996; 103 (8): 1241-1244
6. Bottoni F, Romano M, Massacesi A, et al. Remodeling of the vascular channels in retinal angiomatous proliferations treated with intravitreal triamcinolone acetonide and photodynamic therapy. Graefes Arch Clin Exp Ophthalmol 2006; 244: 1528-1533
7. Schmidt-Erfurth U, Schöltzer-Schrehard U, Cursiefen C, et al. Influence of photodynamic therapy on expression of vascular endothelial growth factor (VEGF), VEGF receptor 3, and pigment epithelium-derived factor. Invest Ophthalmol Vis Sci 2003; 44 (10): 4473-4480
8. Augustin A J, Schmidt-Erfurth U. Verteporfin Therapy Combined with Intravitreal Triamcinolone in All Types of Choroidal Neovascularization due to Age-Related Macular Degeneration. Ophthalmology 2006; 113 (1): 14-22
9. Yoshida T, Ohno-matsui K, Yasuzumi K, et al. Myopic choroidal neovas-cularization: a 10-year follow-up. Ophthalmology 2003; 110 (7): 1297-1305
10. Schmidt-Erfurht U, Laqua H, Scholtzer-Schrehard U, et al. Histopathological changes following photodynamic therapy in human eyes. Arch Ophthalmol 2002; 120 (6): 835-844
11. Schmidt-Erfurth U, Michels S, Barbazetto I, et al. Photodynamic effects on choroidal neovascularization and physiologic choroid. Invest Ophthalmol Vis Sci 2002; 43 (3): 830-840
12. Axer-Siegel R, Ehrlich R, Weinberger D, et al. Photodynamic therapy of subfoveal choroidal neovascularization in high myopia in a clinical setting: visual outcome in relation to age at treatment. Am J Ophthalmol 2004; 138 (4): 602-607
13. Avila M P, Weiter J J, Jalkh A E, et al. Natural history of choroidal neovascularization in degenerative myopia. Ophthalmology 1984; 91 (12): 1573-1581
14. Rabb M F, Garoon I, LaFranco F P. Myopic macular degeneration. Int Ophthalmol Clin 1981; 21 (3): 51-69
15. Yoshida A, Murakami K, Kojima M. Investigation of the vitreo-retino-ciliary barrier by vitreous fluorophotometry. Alteration of the inward permeability of the blood-retinal barrier and the diffusion coefficient of fluorescein in the vitreous with aging in normal subjects. J Jpn Ophthalmol Soc 1986; 90 (4): 589-594
16. Kayazawa F, Tamura S, Tsuji T, et al. The influence of aging on vitreous fluorophotometry. J Jpn Ophthalmol Soc 1983; 87 (6): 380-383
17. Yoshida T, Ohno-Matsui K, Ohtake Y, et al. Long-term visual prognosis of choroidal neovascularization in high myopia. A comparison between age groups. Ophthalmology 2002; 109 (4): 712-719